Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or ...
read more
Danaher has entered into a definitive agreement with General Electric Company (GE) to acquire the Biopharma business of GE Life Sciences (GE Biopharma) for a cash purchase price of approximately $21.4 billion.
read more
Dante Labs, Cambridge Cancer Genomics, and Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, have signed a collaboration agreement.
read more
Tuesday, September 01, 2020
Daré Bioscience and Avomeen announced the companies have signed an agreement under which Avomeen will provide contract product development laboratory services with a team specifically assembled to support the advancement of Daré’s pipeline of ...
read more
Wednesday, August 22, 2018
DarioHealth has entered into an agreement with Attain Health to pilot the DarioEngage platform for the management of cystic fibrosis related diabetes (CFRD).
read more
Wednesday, September 18, 2019
Darmerica is voluntarily recalling two lots, DR4654A and DL4654A, of Quinacrine Dihydrochloride, bulk API powder packaged in Amber HDPE Bottles to the consumer level.
read more
DARTS has obtained an exclusive license for the DARTS patent and is the sole provider of the technology designed to streamline drug development and save pharmaceutical and biotech company’s time and money by identify a drug’s target of actions.
read more
Thursday, February 06, 2014
Almac’s Diagnostics business unit today announced the presentation of an external validation of their ColDx signature for stage II colon cancer recurrence. Following publication of the initial validation study in the Journal of Clinical Oncology (JCO...
read more
Datatrak has chosen to partner with Sisense to provide data visualizations, Business Intelligence dashboards, predictive analytics, and real-time reporting for users of the Datatrak Enterprise Cloud.
read more
Datavant, the leader in helping healthcare organizations securely connect their data, and Ciox Health, the leader in clinical data exchange, announced that they have signed a definitive agreement to merge the two companies in a transaction valued at ...
read more
Datavant and Verge Genomics announced a strategic alliance to unlock the value of pharmaceutical datasets to accelerate drug discovery and development.
read more
Out of an abundance of caution, and with a rapidly growing number of our participants not being able to travel, we’ve made the difficult decision to cancel DCAT Week 2020.
read more
DCPrime BV and apceth Biopharma GmbH announced they have entered into a strategic manufacturing agreement.
read more
DDL, Inc. has implemented a GMP compliant quality system at its Irvine, CA laboratory to govern its container closure integrity testing (CCIT) division.
read more
Particle Sciences has broadened its Drug Enforcement Administration (DEA) registration to become an authorized manufacturer of Schedule I substances.
read more